Oncogene: An International Journal

• 

  Año 2006, Número 11

  • Using high-throughput SNP technologies to study cancer

    L. J. Engle, C. L. Simpson, J. E. Landers

    págs. 1594-1601

    

  • Polymorphisms in the p53 pathway

    E. C. Pietsch

    págs. 1602-1611

    

  • Mouse models of XRCC1 DNA repair polymorphisms and cancer

    W. C. Ladiges

    págs. 1612-1619

    

  • Cyclin D1: polymorphism, aberrant splicing and cancer risk

    K. E. Knudsen

    págs. 1620-1628

    

  • Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions

    R. Weinshilboum, L Wang

    págs. 1629-1638

    

  • Glutathione S-transferase polymorphisms: cancer incidence and therapy

    C. C. McIlwain, D. M. Townsend

    págs. 1639-1648

    

  • N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk

    D. W. Hein

    págs. 1649-1658

    

  • Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer

    R. P. Remmel, S. Nagar

    págs. 1659-1672

    

  • Pharmacogenetics of human cytosolic sulfotransferases

    C. N. Falany, S. Nowell

    págs. 1673-1678

    

  • Cytochrome P450 pharmacogenetics and cancer

    C. Rodriguez-Antona, M. Ingelman-Sundberg

    págs. 1679-1691